NORD has endorsed, and was instrumental in the drafting of, the Food and Drug
Administration Safety Act of 2005 (S.930), introduced April 27 by Senators
Charles Grassley (R-IA) and Christopher Dodd (D-CT). This bill would create a strong and independent
Center for Post-market Drug Evaluation and Research at the FDA, to ensure that
drug safety and effectiveness are top priorities for the agency.
Floor statement introducing the bill
Summary of the bill